Shiseido Company, Limited

OTCPK:SSDO.F Stock Report

Market Cap: US$7.0b

Shiseido Company Valuation

Is SSDO.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SSDO.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SSDO.F ($19.6) is trading below our estimate of fair value ($25.75)

Significantly Below Fair Value: SSDO.F is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SSDO.F?

Key metric: As SSDO.F is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SSDO.F. This is calculated by dividing SSDO.F's market cap by their current revenue.
What is SSDO.F's PS Ratio?
PS Ratio1.1x
SalesJP¥973.38b
Market CapJP¥1.09t

Price to Sales Ratio vs Peers

How does SSDO.F's PS Ratio compare to its peers?

The above table shows the PS ratio for SSDO.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.7x
COTY Coty
1x4.4%US$6.4b
BRBR BellRing Brands
5.1x9.6%US$10.2b
IPAR Interparfums
3x5.0%US$4.3b
ELF e.l.f. Beauty
5.8x15.2%US$7.1b
SSDO.F Shiseido Company
1.1x5.6%US$1.1t

Price-To-Sales vs Peers: SSDO.F is good value based on its Price-To-Sales Ratio (1.1x) compared to the peer average (3.7x).

Price to Sales Ratio vs Industry

How does SSDO.F's PS Ratio compare vs other companies in the US Personal Products Industry?

26 CompaniesPrice / SalesEstimated GrowthMarket Cap
HLF Herbalife
0.2x1.8%US$848.67m
NUS Nu Skin Enterprises
0.2x-0.06%US$358.91m
MED Medifast
0.3x-13.4%US$196.10m
SKIN Beauty Health
0.5x5.7%US$176.25m
SSDO.F 1.1xIndustry Avg. 1.5xNo. of Companies26PS02.44.87.29.612+
26 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: SSDO.F is good value based on its Price-To-Sales Ratio (1.1x) compared to the US Personal Products industry average (1.5x).

Price to Sales Ratio vs Fair Ratio

What is SSDO.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SSDO.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.1x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate SSDO.F's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SSDO.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
US$23.91
0%
12.7%US$30.16US$19.67n/a14
Nov ’25n/a
US$28.00
0%
19.2%US$37.50US$20.09n/a14
Oct ’25n/a
US$28.90
0%
19.2%US$38.71US$20.74n/a14
Sep ’25n/a
US$32.57
0%
17.6%US$42.41US$21.62n/a13
Aug ’25US$31.75
US$32.76
+3.2%
15.6%US$39.04US$22.67n/a12
Jul ’25n/a
US$32.35
0%
15.8%US$38.55US$22.39n/a12
Jun ’25US$32.10
US$33.11
+3.2%
16.6%US$39.32US$22.20n/a11
May ’25US$27.20
US$30.30
+11.4%
18.9%US$37.05US$21.03n/a11
Apr ’25n/a
US$32.06
0%
18.9%US$39.21US$22.25n/a11
Mar ’25n/a
US$32.33
0%
18.3%US$39.02US$22.15n/a11
Feb ’25n/a
US$36.56
0%
23.3%US$51.49US$23.71n/a13
Jan ’25n/a
US$38.51
0%
22.6%US$53.18US$24.49n/a12
Dec ’24US$28.38
US$41.76
+47.2%
23.2%US$55.83US$23.83n/a14
Nov ’24US$31.15
US$48.24
+54.9%
14.4%US$60.05US$33.36n/a15
Oct ’24n/a
US$49.74
0%
13.8%US$61.44US$34.13n/a15
Sep ’24n/a
US$50.09
0%
13.8%US$61.87US$34.37n/a15
Aug ’24n/a
US$51.96
0%
12.7%US$64.24US$36.40US$31.7515
Jul ’24n/a
US$51.28
0%
12.6%US$63.63US$36.06n/a15
Jun ’24n/a
US$51.12
0%
11.1%US$57.81US$36.49US$32.1016
May ’24n/a
US$52.11
0%
10.1%US$60.44US$38.15US$27.2016
Apr ’24n/a
US$53.36
0%
10.1%US$61.89US$39.06n/a16
Mar ’24US$45.34
US$51.23
+13.0%
13.8%US$63.81US$34.51n/a16
Feb ’24n/a
US$52.85
0%
14.9%US$67.45US$36.48n/a16
Jan ’24n/a
US$47.04
0%
14.9%US$61.45US$34.38n/a16
Dec ’23n/a
US$45.95
0%
15.1%US$62.08US$34.73US$28.3817
Nov ’23US$35.20
US$40.89
+16.2%
15.9%US$56.98US$31.88US$31.1518

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Beauty Health

US$176.3m

Designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.

SKIN

US$1.42

7D

-7.2%

1Y

-40.1%

Oddity Tech

US$2.6b

Operates as a consumer tech company that builds digital-first brands for the beauty and wellness industries in the United States and internationally.

ODD

US$45.56

7D

14.6%

1Y

32.5%

Reynolds Consumer Products

US$5.8b

Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.

REYN

US$27.76

7D

1.9%

1Y

6.4%